Abstract

BackgroundMCAD-deficiency is the most common inborn error of fatty acid oxidation now included in many newborn screening programms using MS/MS. During prolonged catabolic episodes, patients may suffer from metabolic decompensation with dysfunction of liver, skeletal- and heart muscle as well as brain. In anabolism, neither clinical symptoms nor biochemical signs of organ dysfunction occur.Case presentationWe report a female patient with MCAD-deficiency in whom at the age of 11 years isolated AST-elevation was found without any clinical or biochemical signs of organ dysfunction. We showed by polyethylene glycol precipitation that macro-AST formation was responsible for this biochemical finding. AST was probably complexed with immunoglobulins possibly related to an allergic disposition. Macro-AST formation is not a special feature of MCAD-deficiency but rather a non-specific, coincidental finding which also occurs in healthy individuals. The general practitioner consulted by the patient before coming to our outpatient clinic for inborn errors of metabolism was worried that isolated AST-elevation indicated cell damage in MCAD-deficiency. He ordered further diagnostic tests like ultrasound, ECG and echocardiography without any pathology.ConclusionIn isolated AST-elevation, macro-AST has to be considered in order to avoid unnecessary, costly and invasive evaluation. This is not only true for healthy persons but for patients with chronic diseases like MCAD as well.

Highlights

  • Medium chain acyl CoA-dehydrogenase (MCAD)-deficiency is the most common inborn error of fatty acid oxidation included in many newborn screening programms using Tandem-mass spectrometry (MS)/MS

  • As fatty acids are the main energy fuel for skeletal and heart muscle as well as liver, dysfunction of these organs may occur during metabolic decompensation in MCAD-deficient patients though other mechanisms may play an additional role

  • We report a female patient with MCAD-deficiency who developed isolated Aspartate aminotransferase (AST)-elevation at the age of 11 years which was supposed to be a sign of chronic toxicity but later turned out to be due to macro-AST

Read more

Summary

Introduction

MCAD-deficiency is the most common inborn error of fatty acid oxidation included in many newborn screening programms using MS/MS. Conclusion: In isolated AST-elevation, macro-AST has to be considered in order to avoid unnecessary, costly and invasive evaluation. As fatty acids are the main energy fuel for skeletal and heart muscle as well as liver, dysfunction of these organs may occur during metabolic decompensation in MCAD-deficient patients though other mechanisms may play an additional role. MCAD-deficiency is a target disease of many newborn screening programs using the MS/MS technique which resulted in a significant reduction of metabolic decompensations and death by avoiding catabolism.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call